Immunogenicity and Safety of GSK Biologicals' Infanrix/Hib in Children

Clinical trial NCT00696423 · COMPLETED

Trial details

NCT number: NCT00696423
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acellular Pertussis Diphtheria Tetanus

Start date: 2008-06-07
Primary completion: 2008-07-26
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.